临床前医疗设备测试服务市场规模、份额、趋势分析报告：按服务、按地区、细分市场预测，2025-2030 年

临床前医疗设备测试服务市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球临床前医疗设备检测服务市场规模将达到65.5亿美元，复合年增长率为9.20%。

疾病的日益普及为製造商提供了不同的医疗设备形成方法，对技术先进的医疗设备的需求不断增加是推动市场成长的主要因素。

近年来，医疗保健产业的技术进步步伐显着加快。医疗设备技术的进步支持疾病管理中更简单、更少痛苦的治疗。此外，医疗设备技术的进步不仅有助于准确、快速的疾病诊断结果，而且还有助于提高基于技术的疾病治疗工具的可负担性。此外，许多政府机构和医疗保健组织也支持医学研究设施。这笔资金主要旨在促进全球医疗创新。因此，医疗设备测试在预期期间的成长得到了不断扩大的技术创新和技术进步的支持。

临床前测试在新产品的开发过程中发挥重要作用。大部分测试应该已经完成，并且在人体试验开始之前应该可以提供报告。根据 ISO-10993，对于直接与患者接触或与血液供应接触的 II 类设备，生物相容性测试结果必须包含在 510(k) 信件中。这表明新设备的风险与领先设备的风险「基本上相当」。测试还可以包括动物和台架测试，以证明新设备的效用、检验电气安全或检查电磁干扰。

COVID-19 为这些服务创造了巨大的需求。上半年成长较为温和，但下半年成长更为强劲，因为疫情期间产业更快采用了新的规范。许多因新冠疫情而暂停的计划已恢復，增加了个人防护装备套件的生产和测试。疫情期间，许多需求旺盛的医疗设备转移了人们对手术所需设备的注意力。 COVID-19 疫苗、人工呼吸器和脉动式血氧监测仪系统是需求激增的主要产品。

临床前医疗设备测试服务市场报告亮点

• 2024年，生物相容性测试领域占据市场主导地位，占45.06%的收益占有率。此测试是医疗设备开发的关键步骤，生物相容性评估提供的资料医疗设备製造商可用于确保患者的器材安全并支援法规遵循很有帮助。
• 化学测试产业预计复合年增长率最快，达 9.63%。进行此测试的目的是对医疗设备製造中使用的化学品进行分类、识别和理解。
• 由于医疗设备测试服务的外包成本较低，预计亚太地区将在 2024 年引领全球市场，在预测期内复合年增长率最快，达到 9.47%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章临床前医疗设备测试服务市场变数、趋势与范围

• 市场体系展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场推动要素分析
  • 市场限制因素分析
• 市场分析工具
  • 波特五力分析
  • PESTEL分析
  • COVID-19 影响分析

第四章临床前医疗设备检测服务市场：服务评估与趋势分析

• 细分仪表板
• 全球临床前医疗设备测试服务市场；方法学变异分析；
• 2018-2030年全球临床前医疗设备检测服务规模及趋势分析（分方法）
• 生物相容性测试
• 化学测试
• 微生物学和无菌测试
  • 微生物附着量测量
  • 热原和内毒素检测
  • 无菌测试和检验
  • 抗菌活性测试
  • 其他的
• 包裹检验

第五章临床前医疗设备测试服务市场：区域估计与趋势分析

• 2024 年及 2030 年区域市场占有率分析
• 区域市场仪表板
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 丹麦
  • 瑞典
  • 挪威
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 泰国
• 拉丁美洲
  • 巴西
  • 阿根廷
• 中东/非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 科威特

第六章 竞争状况

• 公司分类
• 2024 年企业市场分析
• 公司简介
  • SGS SA
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group Plc
  • WUXI APPTEC
  • TUV SUD AG
  • Sterigenics International LLC
  • Nelson Labs
  • North American Science Associates, Inc.
  • Charles River Laboratories International, Inc.

Preclinical Medical Device Testing Services Market Growth & Trends:

The global preclinical medical device testing services market size is expected to reach USD 6.55 billion by 2030, registering a CAGR of 9.20%, according to a new report by Grand View Research, Inc. The rising incidence of diseases has provided manufacturers with different approaches for the formation of medical devices and increasing demand for technologically advanced medical devices are the main factors driving the market growth.

The pace of technological advancement in the healthcare industry has vastly increased in recent years. Medical device technology advancements support simple, painless treatment during disease management. Additionally, advancements in medical device technology help with accurate and quick disease diagnosis results, as well as the affordability of technology-based therapeutic tools for disease treatment. Furthermore, numerous governmental agencies and healthcare institutions support medical research facilities. This funding is primarily intended to promote global health care innovations. The growth of medical device testing in the anticipated period is therefore supported by expanding innovation and technological advancement.

Preclinical testing plays a crucial role in the process of creating new products. Before beginning human testing, most of this testing has been completed and reports should be available. According to ISO-10993, biocompatibility testing results are needed to be included in 510(k) notifications for Class II equipment that has immediate patient contact or contact with the blood supply. This shows that the new device's risks are "substantially equivalent" to the predicate device's risks. In order to show the utility of the new device, validate electrical safety, or examine electromagnetic interference, the testing also involves animal and bench studies.

COVID-19 has created an enormous demand for these services. The growth was not significant during the first half, but it became more significant during the second as the industry adopted the new norms at a faster pace amid the pandemic. Numerous projects that were halted because of COVID have been restarted and PPE kits are witnessing an increase in production and testing. During the pandemic, many medical devices in high demand diverted attention from the equipment needed for surgery. The COVID-19 vaccines, ventilators, and pulse oximeters are the main products that witnessed a spike in demand.

Preclinical Medical Device Testing Services Market Report Highlights:

• In 2024, the biocompatibility tests segment dominated the market, accounting for a revenue share of 45.06%. The test is a critical step for medical device development where an assessment of biocompatibility helps medical device manufacturers ensure the device's safety for patients & provides data that can be used to support regulatory compliance.
• The chemistry test segment is anticipated to exhibit the fastest CAGR of 9.63%. The test is conducted in order to categorize, recognize, and understand the chemicals used in the production of medical devices
• Asia Pacific led the global market in 2024 and is projected to witness the fastest CAGR of 9.47% during the forecast years due to the low cost of outsourcing medical device testing services

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
  • 1.6.2. Bottom-up Approach
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Preclinical Medical Device Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Complexity in product design
    • 3.2.1.2. Strict approval norms
    • 3.2.1.3. Increase in number of small medical device lacking in-house testing capabilities
    • 3.2.1.4. Intense competition in medical device industry
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Legal and Regulatory Issues
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Preclinical Medical Device Testing Services Market: Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Preclinical Medical Device Testing Services Market; Method Movement Analysis
• 4.3. Global Preclinical Medical Device Testing Services Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
• 4.4. Biocompatibility Tests
  • 4.4.1. Biocompatibility tests market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Chemistry Test
  • 4.5.1. Chemistry test market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Microbiology & Sterility Testing
  • 4.6.1. Microbiology & sterility testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Bioburden Determination
    • 4.6.2.1. Bioburden determination market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Pyrogen & Endotoxin Testing
    • 4.6.3.1. Pyrogen & endotoxin testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Sterility Test and Validation
    • 4.6.4.1. Sterility test and validation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.2. Ethylene Oxide (EO) gas sterilization
      • 4.6.4.2.1. Ethylene oxide (EO) gas sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.3. Gamma-irradiation
      • 4.6.4.3.1. Gamma-irradiation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.4. E-beam sterilization
      • 4.6.4.4.1. E-beam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.5. X-ray sterilization
      • 4.6.4.5.1. X-ray sterilization market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.5. Antimicrobial Activity Testing
    • 4.6.5.1. Antimicrobial activity testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Package Validation
  • 4.7.1. Package validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preclinical Medical Device Testing Services Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. North America
  • 5.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Competitive scenario
    • 5.3.2.3. Regulatory framework
    • 5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Competitive scenario
    • 5.3.3.3. Regulatory framework
    • 5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Mexico
    • 5.3.4.1. Key country dynamics
    • 5.3.4.2. Competitive scenario
    • 5.3.4.3. Regulatory framework
    • 5.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. UK
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Competitive scenario
    • 5.4.2.3. Regulatory framework
    • 5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Germany
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Competitive scenario
    • 5.4.3.3. Regulatory framework
    • 5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Competitive scenario
    • 5.4.4.3. Regulatory framework
    • 5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Italy
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Competitive scenario
    • 5.4.5.3. Regulatory framework
    • 5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Spain
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Competitive scenario
    • 5.4.6.3. Regulatory framework
    • 5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Denmark
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Competitive scenario
    • 5.4.7.3. Regulatory framework
    • 5.4.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Sweden
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Competitive scenario
    • 5.4.8.3. Regulatory framework
    • 5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.9. Norway
    • 5.4.9.1. Key country dynamics
    • 5.4.9.2. Competitive scenario
    • 5.4.9.3. Regulatory framework
    • 5.4.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Japan
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Competitive scenario
    • 5.5.2.3. Regulatory framework
    • 5.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.3. China
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Competitive scenario
    • 5.5.3.3. Regulatory framework
    • 5.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.4. India
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Competitive scenario
    • 5.5.4.3. Regulatory framework
    • 5.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.5. Australia
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Competitive scenario
    • 5.5.5.3. Regulatory framework
    • 5.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.6. South Korea
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Competitive scenario
    • 5.5.6.3. Regulatory framework
    • 5.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.7. Thailand
    • 5.5.7.1. Key country dynamics
    • 5.5.7.2. Competitive scenario
    • 5.5.7.3. Regulatory framework
    • 5.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Latin America
  • 5.6.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Brazil
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Competitive scenario
    • 5.6.2.3. Regulatory framework
    • 5.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.3. Argentina
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Competitive scenario
    • 5.6.3.3. Regulatory framework
    • 5.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. MEA
  • 5.7.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.2. South Africa
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Competitive scenario
    • 5.7.2.3. Regulatory framework
    • 5.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.3. Saudi Arabia
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Competitive scenario
    • 5.7.3.3. Regulatory framework
    • 5.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.4. UAE
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Competitive scenario
    • 5.7.4.3. Regulatory framework
    • 5.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.5. Kuwait
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Competitive scenario
    • 5.7.5.3. Regulatory framework
    • 5.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Company Market Position Analysis, 2024
• 6.3. Company Profiles
  • 6.3.1. SGS SA
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Service benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. Eurofins Scientific
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Service benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Pace Analytical Services LLC
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Service benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Intertek Group Plc
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Service benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. WUXI APPTEC
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Service benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. TUV SUD AG
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Service benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Sterigenics International LLC
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Service benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Nelson Labs
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Service benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. North American Science Associates, Inc.
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Service benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Charles River Laboratories International, Inc.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Service benchmarking
    • 6.3.10.4. Strategic initiatives

List of Tables

• Table 1. List of Tables
• Table 2. List of Secondary Sources
• Table 3. List of Abbreviations
• Table 4. Global Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 5. Global Preclinical Medical Device Testing Services Market, by Region, 2018 - 2030 (USD Million)
• Table 6. North America Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 7. North America Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 8. U.S. Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 9. Canada Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 10. Mexico Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 11. Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 12. Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 13. UK Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 14. Germany Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 15. France Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 16. Italy Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 17. Spain Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 18. Denmark Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 19. Sweden Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 20. Norway Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 21. Asia Pacific Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 22. Asia Pacific Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 23. Japan Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 24. China Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 25. India Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 26. Thailand Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 27. South Korea Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 28. Australia Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 29. Latin America Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 30. Latin America Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 31. Brazil Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 32. Argentina Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 33. Middle East & Africa Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 34. Middle East & Africa Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 35. South Africa Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 36. Saudi Arabia Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 37. UAE Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 38. Kuwait Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for Market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Preclinical Medical Device Testing Services Market revenue, 2018 - 2030 (USD Million)
• Fig. 10 Preclinical Medical Device Testing Services Market snapshot
• Fig. 11 Preclinical Medical Device Testing Services Market driver impact
• Fig. 12 Preclinical Medical Device Testing Services Market restraint impact
• Fig. 13 Preclinical Medical Device Testing Services Market: Service takeaways (USD Million)
• Fig. 14 Preclinical Medical Device Testing Services Market: Service movement analysis
• Fig. 15 Biocompatibility Tests Market, 2018 - 2030 (USD Million)
• Fig. 16 Chemistry Test Market, 2018 - 2030 (USD Million)
• Fig. 17 Microbiology & Sterility Testing Market, 2018 - 2030 (USD Million)
• Fig. 18 Bioburden Determination Market, 2018 - 2030 (USD Million)
• Fig. 19 Pyrogen & Endotoxin Testing Market, 2018 - 2030 (USD Million)
• Fig. 20 Sterility Test and Validation Market, 2018 - 2030 (USD Million)
• Fig. 21 Ethylene Oxide (EO) gas sterilization Market, 2018 - 2030 (USD Million)
• Fig. 22 Gamma-irradiation Market, 2018 - 2030 (USD Million)
• Fig. 23 E-beam sterilization Market, 2018 - 2030 (USD Million)
• Fig. 24 X-ray sterilization Market, 2018 - 2030 (USD Million)
• Fig. 25 Antimicrobial Activity Testing Market, 2018 - 2030 (USD Million)
• Fig. 26 Others Market, 2018 - 2030 (USD Million)
• Fig. 27 Package Validation Market, 2018 - 2030 (USD Million)
• Fig. 28 Regional Marketplace: Key takeaways
• Fig. 29 Regional outlook, 2024 & 2030
• Fig. 30 North America Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 32 Canada Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 33 Mexico Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 34 Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 35 UK Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 36 Germany Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 37 France Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 38 Italy Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 39 Spain companion animal Health Market, 2018 - 2030 (USD Million)
• Fig. 40 Sweden Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 41 Denmark Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 42 Norway Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 43 Asia Pacific Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 44 Japan Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 45 China Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 46 India Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 47 Thailand Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 48 South Korea Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 49 Australia Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 52 Argentina Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 53 Middle East & Africa Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 54 South Africa Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 56 UAE Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 58 Market participant categorization